Sat09202014

Last update 09:53:15 AM EST

FDA Approves Baxter's Rixubis for Treatment of Children with Hemophilia B

FDA Approves Baxter's Rixubis for Treatment of Children with Hemophilia B

Today, the US Food and Drug Administration (FDA) approved Baxter Internation...

Study Finds PSA Screening Guidelines Have Little Effect

Study Finds PSA Screening Guidelines Have Little Effect

A new study found that the guidelines recommending that elderly men should n...

Boehringer Ingelheim Licenses CureVac's Investigational Cancer Vaccine

Boehringer Ingelheim Licenses CureVac's Investigational Cancer Vaccine

Boehringer Ingelheim has gained exclusive global rights to CureVac’s investi...

Gilead's Experimental Pancreatic Cancer Drug Fails its Mid-Stage Trial

Gilead's Experimental Pancreatic Cancer Drug Fails its Mid-Stage Trial

Today, Gilead Sciences, Inc. announced that its investigational pancreatic c...

Abcodia and OncoCyte Partner for Breast Cancer Diagnostic

Abcodia and OncoCyte Partner for Breast Cancer Diagnostic

Abcodia has partnered with OncoCyte Corporation, a subsidiary of BioTime, In...

Endo Offers to Acquire Auxilium for $2.2 Billion

Endo Offers to Acquire Auxilium for $2.2 Billion

Specialty healthcare company Endo International offered to acquire Auxilium ...

Carmine DeNardo, President and Chief Executive Officer for ReCept Pharmacy, Joins NASP / SPAARx Board of Directors

Carmine DeNardo, President and Chief Executive Officer for ReCept Pharmacy, Joins NASP / SPAARx Board of Directors

DeNardo joins leaders representing all specialty pharmacy stakeholders on th...

Gilead Strikes Deal for Generic Versions of Hepatitis C Drugs for Poor Countries

Gilead Strikes Deal for Generic Versions of Hepatitis C Drugs for Poor Countries

Gilead Sciences, Inc. has reached a deal with seven India-based generic phar...

Merck's Osteoporosis Drug Demonstrates Positive Late-Stage Results

Merck's Osteoporosis Drug Demonstrates Positive Late-Stage Results

Merck recently announced positive results from a late-stage fracture outcome...

FDA Approves HyQvia for Patients with Primary Immunodeficiency

FDA Approves HyQvia for Patients with Primary Immunodeficiency

Baxter International Inc. and partner Halozyme Therapeutics, Inc. recently a...

Regeneron's Eylea Awarded Breakthrough Therapy Designation by the FDA

Regeneron's Eylea Awarded Breakthrough Therapy Designation by the FDA

The US Food and Drug Administration (FDA) has granted Regeneron Pharmaceutic...

Viamet's Antifungal Drug Receives Orphan Drug Designation from the FDA

Viamet's Antifungal Drug Receives Orphan Drug Designation from the FDA

Durham-based Viamet Pharmaceuticals recently announced that the US Food and ...